Understanding drug movement, metabolism, and enzyme behavior
What a drug DOES at its target site
How the body MOVES the drug around
Every rate-limiting enzyme produces a sigmoidal (S-shaped) kinetic curve because of:
Enzyme active sites are NOT saturated → there's room for more substrate
Enzyme active sites are ALL SATURATED → no room for more
Loading dose trick: Bypasses first-order kinetics → gets drug to steady state (zero-order) faster
How much "fuel" you're feeding to the enzyme
Key: Hyperbolic (curved) shape. Km point shows ½ Vmax. Reaction rate approaches Vmax asymptotically.
Key: Straight line. Y-intercept = 1/Vmax, X-intercept = -1/Km, Slope = Km/Vmax
| Property | Competitive | Non-Competitive |
|---|---|---|
| Binding Site | SAME active site as substrate | DIFFERENT allosteric site |
| Similarity | Similar properties to substrate | Different properties |
| Effect on Km | ↑Km (decreased affinity) | Km stays the same |
| Effect on Vmax | Vmax stays the same | ↓Vmax (decreased efficacy) |
| Can Add Substrate to Overcome? | YES (↑Km but can add more) | NO (can't overcome it) |
| Real-World Use | 90% of drugs are competitive | Deadly diseases (worse prognosis than side effects) |
| Overdose | REVERSIBLE | IRREVERSIBLE |
| Method | Frequency | Why? |
|---|---|---|
| Acetylation | ~90% of the time | Body has lots of acetyl-CoA from Krebs cycle |
| Adenylation | Also available | Using adenosine derivatives |
| Sulfate | Also available | Sulfate groups readily available |
| Phosphorylation | Also available | Phosphate groups readily available |
| Type | Chains | Frequency in Adults |
|---|---|---|
| Hb A (Adult) | 2α + 2β | ~98% |
| Hb A2 | 2α + 2δ | ~2% |
| Hb F (Fetal) | 2α + 2γ | Fetal only (but persists in some adults) |